Borderline Ovarian Serous Tumor
3 clinical trials · Condition
◉ Watch Borderline Ovarian Serous Tumor
| Record | Firm | Date |
|---|---|---|
| Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer (NCT02101788) | National Cancer Institute (NCI) | 2014-04-11 |
| Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer (NCT00551070) | National Cancer Institute (NCI) | 2007-12-17 |
| Collecting Tumor Samples From Patients With Gynecological Tumors (NCT00897442) | Gynecologic Oncology Group | 1992-06-01 |
Track Borderline Ovarian Serous Tumor automatically
Every clearance here is in the API, with alerts when new ones post.